Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Hospital of the University of Pennsylvania
mi
from
Philadephia, PA
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Hospital of the University of Pennsylvania
mi
from
Philadephia, PA
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
University of Pittsburgh Medical Center (UPMC)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Texas Tech University Health Science Center (HSC)- Amarillo
mi
from
Amarillo, TX
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Texas Tech University Health Science Center (HSC)- Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Texas Children's Hospital
mi
from
Houston, TX
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Texas Tech HSC-Lubbock, TX
mi
from
Lubbock, TX
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Texas Tech HSC-Lubbock, TX
mi
from
Lubbock, TX
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Madigan Army Medical Center (MAMC)
mi
from
Tacoma, WA
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Madigan Army Medical Center (MAMC)
mi
from
Tacoma, WA
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
Boston Med Ctr
mi
from
Boston, MA
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated:  12/14/2015
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
A Randomized, Open-Label, Phase 2, Multicenter Safety and Exploratory Efficacy Study of Investigational Anti-Influenza Immune Plasma for the Treatment of Influenza (IRC002)
Status: Enrolling
Updated: 12/14/2015
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 2 Virus Vaccine, rHPIV2 15C/948L/Δ1724 Lot PIV2#109C, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV2-Seropositive Children 15 to 59 Months of Age, and HPIV2-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated:  12/14/2015
Johns Hopkins University, Bloomberg School of Public Health
mi
from
Baltimore, MD
Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 2 Virus Vaccine, rHPIV2 15C/948L/Δ1724 Lot PIV2#109C, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV2-Seropositive Children 15 to 59 Months of Age, and HPIV2-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated: 12/14/2015
Johns Hopkins University, Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Exploratory Evaluation of Host Biomarkers That Predict the Vaccine Virus Replication and Immunogenicity of Seasonal and Pandemic Formulations of Live Attenuated Influenza A Virus Vaccines Based on the A/Ann Arbor/6/60 ca Master Donor Virus (MDV)
Status: Enrolling
Updated:  12/14/2015
University of Rochester Medical Center: Facility for Evaluation of Flu Vaccines
mi
from
Rochester, NY
Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Exploratory Evaluation of Host Biomarkers That Predict the Vaccine Virus Replication and Immunogenicity of Seasonal and Pandemic Formulations of Live Attenuated Influenza A Virus Vaccines Based on the A/Ann Arbor/6/60 ca Master Donor Virus (MDV)
Status: Enrolling
Updated: 12/14/2015
University of Rochester Medical Center: Facility for Evaluation of Flu Vaccines
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults
Evaluation of Priming by Pandemic Live Attenuated Influenza Vaccine (LAIV) on the Subsequent Response to Inactivated H7N7 Vaccine in Healthy Adults: A Non-Randomized, Open Label Study
Status: Enrolling
Updated:  12/14/2015
University of Rochester
mi
from
Rochester, NY
Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults
Evaluation of Priming by Pandemic Live Attenuated Influenza Vaccine (LAIV) on the Subsequent Response to Inactivated H7N7 Vaccine in Healthy Adults: A Non-Randomized, Open Label Study
Status: Enrolling
Updated: 12/14/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from
Little Rock, AR
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Arkansas - Arkansas Childrens Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Wilmington Hospital Health Center
mi
from
Wilmington, DE
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Wilmington Hospital Health Center
mi
from
Wilmington, DE
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Florida
mi
from
Gainesville, FL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Children's Memorial Hospital-Northwestern University
mi
from
Chicago, IL
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Children's Memorial Hospital-Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Iowa Hospital
mi
from
Iowa City, IA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Iowa Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Boston Children's
mi
from
Boston, MA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Boston Children's
mi
from
Boston, MA
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Michigan
mi
from
Ann Arbor, MI
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
St. Louis University School of Medicine
mi
from
St. Louis, MO
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
St. Louis University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Oak Orchard Community Health Center
mi
from
Brockport, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Oak Orchard Community Health Center
mi
from
Brockport, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Honeoye Falls Family Medicine
mi
from
Honeoye Falls, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Honeoye Falls Family Medicine
mi
from
Honeoye Falls, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Mendon Pediatrics
mi
from
Mendon, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Mendon Pediatrics
mi
from
Mendon, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Long Pond Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Goodman Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Goodman Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Parkway Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Parkway Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
English Road Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
English Road Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
12 Corner Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
12 Corner Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Westside Pediatrics
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Westside Pediatrics
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Ridgewood Med-Peds
mi
from
Rochester, NY
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Ridgewood Med-Peds
mi
from
Rochester, NY
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
Baylor College of Medicine/Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
The University of Texas, Houston
mi
from
Houston, TX
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated:  12/16/2015
University of Washington Medical Center
mi
from
Seattle, WA
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Adolescent Vaccination in the Medical Home
Status: Enrolling
Updated: 12/16/2015
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Residual Sample Collection for Respiratory Viral Panel
De-identified Residual Sample Collection for the Respiratory Viral Panel on the GenMark Sample to Answer Platform (ARM 1)
Status: Enrolling
Updated:  12/23/2015
Penn State Hershey Medical Center
mi
from
Hershey, PA
Residual Sample Collection for Respiratory Viral Panel
De-identified Residual Sample Collection for the Respiratory Viral Panel on the GenMark Sample to Answer Platform (ARM 1)
Status: Enrolling
Updated: 12/23/2015
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
A Pilot Single Arm Study of High-Dose Influenza Vaccine Immunogenicity in Patients With Central Nervous System Tumors
Status: Enrolling
Updated:  12/28/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
mi
from
Baltimore, MD
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
A Pilot Single Arm Study of High-Dose Influenza Vaccine Immunogenicity in Patients With Central Nervous System Tumors
Status: Enrolling
Updated: 12/28/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
A Pilot Single Arm Study of High-Dose Influenza Vaccine Immunogenicity in Patients With Central Nervous System Tumors
Status: Enrolling
Updated:  12/28/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
A Pilot Single Arm Study of High-Dose Influenza Vaccine Immunogenicity in Patients With Central Nervous System Tumors
Status: Enrolling
Updated: 12/28/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines
Evaluation of the Safety and Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines Representing Different Clades
Status: Enrolling
Updated:  12/31/2015
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases
mi
from
Rochester, NY
Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines
Evaluation of the Safety and Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines Representing Different Clades
Status: Enrolling
Updated: 12/31/2015
University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
A Phase I, Dose-Ranging Safety and Immunogenicity Study of an Adenovirus-vectored Intranasal, Pandemic (Hemagglutinin H5) Influenza Vaccine, ADhVN1203/04.H5, in Healthy Adults
Status: Enrolling
Updated:  12/31/2015
Alabama Vaccine Research Center (UAB)
mi
from
Birmingham, AL
Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
A Phase I, Dose-Ranging Safety and Immunogenicity Study of an Adenovirus-vectored Intranasal, Pandemic (Hemagglutinin H5) Influenza Vaccine, ADhVN1203/04.H5, in Healthy Adults
Status: Enrolling
Updated: 12/31/2015
Alabama Vaccine Research Center (UAB)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Santa Rosa, CA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Council Bluffs, IA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Metairie, LA
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Safety and Immunogenicity Among Adults of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2015-2016 Formulations
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Mail Outreach To Increase Vaccination Acceptance Through Engagement
Mail Outreach To Increase Vaccination Acceptance Through Engagement
Status: Enrolling
Updated:  1/7/2016
Centers for Medicare & Medicaid Services
mi
from
Baltimore, MD
Mail Outreach To Increase Vaccination Acceptance Through Engagement
Mail Outreach To Increase Vaccination Acceptance Through Engagement
Status: Enrolling
Updated: 1/7/2016
Centers for Medicare & Medicaid Services
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated:  1/19/2016
51, Northern California Clinical Research Center
mi
from
Redding, CA
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated: 1/19/2016
51, Northern California Clinical Research Center
mi
from
Redding, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated:  1/19/2016
47, Benchmark Research
mi
from
Sacramento, CA
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated: 1/19/2016
47, Benchmark Research
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated:  1/19/2016
46, Johnson County Clinical Trials
mi
from
Lenexa, KA
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated: 1/19/2016
46, Johnson County Clinical Trials
mi
from
Lenexa, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated:  1/19/2016
49, Heartland Research Associates, LLC
mi
from
Wichita, KA
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated: 1/19/2016
49, Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated:  1/19/2016
43, Central Kentucky Research Associates
mi
from
Lexington, KY
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Phase I Multi-center, Observer-Blind, Randomized, Dose-Ranging Study of Adjuvanted and Non-Adjuvanted Cell Culture-Derived, Inactivated Novel Swine Origin A/H3N2v Monovalent Subunit Influenza Virus Vaccine (H3N2c) in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to < 65 Years and Elderly ≥ 65 Years and Older.
Status: Enrolling
Updated: 1/19/2016
43, Central Kentucky Research Associates
mi
from
Lexington, KY
Click here to add this to my saved trials